You are here:Home-Chemical Inhibitors & Agonists-GPCR-5-HT Receptor-PF-04781340
PF-04781340

Chemical Structure : PF-04781340

CAS No.: 1648726-56-0

PF-04781340 (PF 04781340, PF04781340)

Catalog No.: PC-61080Not For Human Use, Lab Use Only.

PF-04781340 is a potent, selective, CNS penetrant 5-HT2C receptor agonist with Ki of 3 nM and EC50 of 9 nM, without significant P-gp efflux liability.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    PF-04781340 is a potent, selective, CNS penetrant 5-HT2C receptor agonist with Ki of 3 nM and EC50 of 9 nM, without significant P-gp efflux liability.
    PF-04781340 displays >150-fold selectivity over 5-HT2B receptors agonism (EC50=1484 nM).
    PF-04781340 exhibits good metabolic stability in human liver microsomes (HLM) and moderate to good passive permeability in RRCK cells.

    Physicochemical Properties

    M.Wt 267.376
    Formula C17H21N3
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    3-benzyl-N-methyl-6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepin-1-amine

    References

    1. Dvorak CA, et al. ACS Med Chem Lett. 2015 Jul 20;6(9):1015-8.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: